Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,980 | -26,573 | -12,992 | -63,854 | -42,896 |
| Depreciation Amortization | 120 | 82 | 33 | 162 | 121 |
| Accounts payable and accrued liabilities | 132 | -1,211 | 361 | N/A | -1,705 |
| Other Working Capital | -2,406 | -8,637 | -4,700 | 6,710 | 2,182 |
| Other Operating Activity | 5,750 | 4,886 | 1,626 | 19,620 | 13,439 |
| Operating Cash Flow | $-46,384 | $-31,453 | $-15,672 | $-37,362 | $-28,859 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -340 | -35 | N/A | -166 | -166 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -100 |
| Other Investing Activity | 0 | 0 | 0 | -100 | 0 |
| Investing Cash Flow | $-340 | $-35 | $N/A | $-266 | $-266 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -4,500 | -3,000 | -1,500 | N/A | 36,000 |
| Common Stock Issued | 194,607 | 425 | 3 | N/A | N/A |
| Other Financing Activity | 166,190 | 168,189 | 169,498 | 34,941 | -50 |
| Financing Cash Flow | $356,297 | $165,614 | $168,001 | $34,941 | $35,950 |
| Exchange Rate Effect | -56 | 2 | 19 | 0 | 65 |
| Beginning Cash Position | 24,957 | 24,957 | 24,957 | 27,644 | 27,644 |
| End Cash Position | 334,474 | 159,085 | 177,305 | 24,957 | 34,534 |
| Net Cash Flow | $309,517 | $134,128 | $152,348 | $-2,687 | $6,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,384 | -31,453 | -15,672 | -37,362 | -28,859 |
| Capital Expenditure | -340 | -35 | N/A | N/A | -166 |
| Free Cash Flow | -46,724 | -31,488 | -15,672 | -37,362 | -29,025 |